Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

IJMDC. 2024; 8(8): 2179-2181


Extrapyramidal side effects following intravenous morphine administration in a young patient with sickle cell disease

Yahia Yaseen Akeely, Swaid Raza Saulat, Mohamed Saied Karar, Mohamed Ismail Khider, Ibrahim Showaihi.




Abstract

Background: Antipsychotic medicines are the primary cause of extrapyramidal symptoms (EPSs). Intravenous morphine is very rarely if ever, related to this condition. EPS is a group of different forms, such as acute dystonia, acute akathisia, parkinsonism, tardive dyskinesia, and tardive akathisia. Considering intravenous morphine, however, these kinds of adverse effects are rarely experienced. The most commonly written possible side effects of morphine include dizziness, respiratory depression, allergy, and rarely if ever mentioned, such side effects.
Case Presentation: A case of a young female known to have sickle cell disease was presented. She arrived, complaining of severe pain throughout her body. She received morphine intravenously for pain relief. Within 15 minutes, she developed neck spasms and abnormal eye-jerky movements. The treating physician treated her immediately with anticholinergic diphenhydramine 25 mg intravenously, which reversed the spasm, and the patient recovered in a few minutes. She was admitted to the medical ward for a four-day stay. The absence of morphine during her admission days prevented any recurrence of her symptoms.
Conclusion: This case provides detailed information and educates clinicians about the potential adverse effects of morphine. Furthermore, early detection and quick treatment are of utmost importance.

Key words: Acute dystonia, extrapyramidal side effects, morphine, sickle cell disease, case report






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.